Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States
Bladder Cancer · 17.11.2023 · 9 (4) · 345-353
DOI: 10.3233/blc-230062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 06.12.2023. Verfasst von Isabella R Pompa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Bladder cancer is the tenth leading cause of cancer death in the United States (US). Advances in diagnosis, imaging, and treatments have led to improvements in bladder cancer management. OBJECTIVE: To evaluate longitudinal bladder cancer mortality trends from 1999–2020 in the US by gender, race, ethnicity, age, geographic region, and urbanization category. METHODS: Age-adjusted bladder cancer death and incidence rates of individuals in the US of all ages between 1999–2020 were obtained using the CDC WONDER and NAACCR databases. Trends and average annual percent changes (AAPC) in age-adjusted Bladder Cancer-Specific Mortality (BCSM) and incidence rates were estimated. Data were analyzed from May 2023 to October 2023. RESULTS: From 1999–2020, overall BCSM decreased by 0.4% annually, with a dramatic decrease in deaths between 2015–2020 (AAPC: –2.0% [95% CI: –2.6,–1.3]). However, BCSM rates and metastatic malignant bladder cancer incidence rates from 1999–2020 increased for individuals≥85 years old (AAPC for BCSM: 0.8% [95% CI:0.5,1.1]; AAPC for metastatic malignant incidence: 2.5% [95% CI: 2.0,2.9]). Increases in BCSM were found for certain years in the South, in rural areas, and for Non-Hispanic White and Asian or Pacific Islander individuals. CONCLUSIONS: Overall mortality from bladder cancer has been decreasing in the US over two decades. Upon disaggregation, increasing trends were found for BCSM and for metastatic malignant bladder cancer incidence for individuals≥85 years old from 1999–2020. Further evaluation of these trends is essential to understand how to target specific populations to improve patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Pompa, I. R., Qi, D., Ghosh, A., Goldberg, S. I., Chino, F., Efstathiou, J. A., & Kamran, S. C. (2023). Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States. Bladder Cancer, 9(4), 345-353. https://doi.org/10.3233/blc-230062
Vancouver
Pompa IR, Qi D, Ghosh A, Goldberg SI, Chino F, Efstathiou JA, et al. Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States. Bladder Cancer. 2023;9(4):345-353. doi:10.3233/blc-230062
BibTeX
@article{Pompa2023,
author = {Pompa, Isabella R and Qi, David and Ghosh, Anushka and Goldberg, Saveli I and Chino, Fumiko and Efstathiou, Jason A and Kamran, Sophia C},
title = {Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States},
journal = {Bladder Cancer},
year = {2023},
volume = {9},
number = {4},
pages = {345--353},
doi = {10.3233/blc-230062}
}
EUVIMED